VivoSim Labs (VIVS) Gains from Investment Securities (2012 - 2017)
VivoSim Labs (VIVS) posted Gains from Investment Securities of -$8000.0 for Q1 2017, down 700.0% on a QoQ basis from -$1000.0 in Q4 2016, and up 20.0% year-over-year from -$6666.7 in Q1 2016.
Powered by 
Analysis
VivoSim Labs (VIVS) Gains from Investment Securities (2012 - 2017) Analysis & Trends
VivoSim Labs has reported Gains from Investment Securities for 6 years, with the latest figure at -$8000.0 in Q1 2017.
- On a quarterly basis, Gains from Investment Securities rose 20.0% year-over-year to -$8000.0 in Q1 2017; TTM through Dec 2017 was -$8000.0, a 33.33% decrease from a year earlier, with the FY2017 full-year figure at -$4000.0, down 123.53% from the prior year.
- Gains from Investment Securities was -$8000.0 for Q1 2017 at VivoSim Labs, down from -$1000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $4.8 million in Q3 2013, with the low at -$172000.0 in Q1 2015.
- Average Gains from Investment Securities over 5 years is $357769.2, with a median of -$1000.0 recorded in 2016.
- The sharpest annual moves came in 2015 and 2016: Gains from Investment Securities plunged 105.0% in 2015, then jumped 94.19% in 2016.
- Over 5 years, Gains from Investment Securities stood at $4.8 million in 2013, then slumped by 99.17% to $40000.0 in 2014, then plunged by 105.0% to -$2000.0 in 2015, then soared by 50.0% to -$1000.0 in 2016, then tumbled by 700.0% to -$8000.0 in 2017.
- The last three Gains from Investment Securities figures came in at -$8000.0 (Q1 2017), -$1000.0 (Q4 2016), and $5000.0 (Q2 2016), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | -8,000.00 |
| Dec 31, 2016 | -1,000.00 |
| Jun 30, 2016 | 5,000.00 |
| Mar 31, 2016 | -10,000.00 |
| Dec 31, 2015 | -2,000.00 |
| Sep 30, 2015 | -9,000.00 |
| Jun 30, 2015 | 38,000.00 |
| Mar 31, 2015 | -172,000.00 |
| Dec 31, 2014 | 40,000.00 |
| Sep 30, 2014 | -94,000.00 |
| Jun 30, 2014 | 30,000.00 |
| Sep 30, 2013 | 4.81 Mn |
| Jun 30, 2013 | 23,000.00 |
| Mar 31, 2012 | 13.51 Mn |